Start of Main Content
News Info | 08/14/2025

GLP-1 Weight Loss Medication Insurance Changes

By  Atrius Health
Up close photo of a person in a magenta colored shirt holding a weight loss injection pen in their hands

At Atrius Health, we care about your health and well-being. If weight loss is a personal goal for health reasons, our clinicians work hard to partner with you in moving toward that goal.

In some instances, GLP-1 and GLP-1-like medications (which are marketed under brand names such as Zepbound®, Wegovy®, and Saxenda®) are used to assist with weight management. As patients who use these medications may know, insurance coverage for these products is changing significantly. Depending on your health plan, some of these insurance coverage changes took effect on July 1, 2025, and others are scheduled for January 1, 2026.

If you are taking one of these medications, you should expect direct notification via letter from your health plan regarding any coverage changes. If these coverage changes impact you, please schedule an appointment with your Atrius Health prescribing team before the end of this year to review your treatment plan and options.

If you have any questions about your insurance coverage for these medications, please contact your health plan directly. They can provide the most accurate information about plan-specific changes and coverage.

Atrius Health Logo

About The Author

Atrius Health

Atrius Health, an innovative healthcare leader, delivers an effective system of connected care for adult and pediatric patients at more than 28 medical practice locations in eastern Massachusetts. By establishing a solid foundation of shared decision making, understanding and trust with each of its patients, Atrius Health enhances their health and enriches their lives.

More from this author